Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
PHARMASIMPLE [BE0974302342/ALPHS]   
[09/08/2022]

PHARMASIMPLE : Pharmasimple annonce avoir pris une participation de 5% dans Phytocann Group, expert suisse du CBD en Europe

Pharmasimple annonce avoir pris une participation de 5% dans Phytocann Group, expert suisse du CBD en Europe HoudengGoegnies Belgique, le 9 août 2022, 18h Pharmasimple Code ISIN : BE0974302342. Mnémonique: ALPHS annonce la signature d'un partenariat stratégique et financier avec Phytocann Group, entreprise verticalement intégrée et pionnière du CBD en... See more
 
 
UCB [BE0003739530/UCB]   
[05/08/2022]

UCB : UCB Media Room - Transparency notification FMR LLC

https://mb.cision.com/Public/18595/3610818/b8115ff58f13dacd_800x800ar.png Transparency notification FMR LLC Brussels Belgium, 5 August 2022 =E2=80=93 20:05 CEST =E2=80=93 Regulate= d information 1. Summary of the notification Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large = shareholdings, UCB=C2=A0SA/NV announces that it received a transparency... See more
 
UCB [BE0003739530/UCB]   
[05/08/2022]

UCB : UCB Media Room - Disposal of own shares

https://mb.cision.com/Public/18595/3610800/ac752e88efb06bb5_800x800ar.png Disposal of own shares Brussels Belgium, 5 August 2022 =E2=80=93 20:00 CEST =E2=80=93 Regulate= d information In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB announces that, following exercises o= f stock options by members of its personnel,... See more
 
 
UCB [BE0003739530/UCB]   
[28/07/2022]

UCB : UCB Media Room: Half Year Results 2022

https://mb.cision.com/Public/18595/3607782/826d4973ba246892_800x800ar.png Strong first six months =E2=80=93 UCB with continued delivery and strong= resilience =C2=B7 Revenue increased to =E2=82=AC 2.93 billion 5%; 3% CER^1, net sa= les to =E2=82=AC 2.70 billion 2%; 0% CER =E2=80=93 impacted by generic e= rosion to Vimpat/U.S. and E Keppra/Japan =C2=B7 Underlying profitability adj....